Skip to Content

Tag: Nabil Shabshab


Vendors

Inogen tries to ‘block and tackle’ supply chain challenges

May 6, 2022Liz Beaulieu, Editor

GOLETA, Calif. – Supply chain challenges, as well as a temporary shutdown at facilities in Texas and California earlier this year, forced Inogen to prioritize available supply in the first quarter of 2022 to its domestic direct-to-consumer and rental channels, contributing to an 83.4% drop in revenues for its business-to-business channel.  “As of early May, we have started shipments to our domestic B2B channel in order to alleviate some of the backlog in our system,”...

Inogen, Nabil Shabshab, Portable Oxygen Concentrators


Read Full Articlered right arrow icon

Vendors

Inogen: DTC sales up, B2B sales down

February 25, 2022HME News Staff

GOLETA, Calif. – Inogen reported revenue of $76.4 million for the fourth quarter of 2021, an increase of 3.3% over the same period in 2020, driven by a 23.3% in domestic direct-to-consumer sales to $33 million.  Domestic business-to-business sales in the fourth quarter of 2021 decreased 57.6% to $10.3 million compared to $24.2 million in the fourth quarter of 2020, primarily due to the supply chain constraints that limited product availability in this channel.  Rental revenue...

Inogen, Nabil Shabshab, Portable Oxygen Concentrator


Read Full Articlered right arrow icon

Vendors

Inogen temporarily halts manufacturing at some locations

January 12, 2022HME News Staff

GOLETA, Calif. – Inogen says its revenues are expected to increase for the fourth quarter of 2021, but a chip shortage has forced the company to temporarily suspend manufacturing operations at its Texas and California locations.  Inogen doesn’t expect to furlough any employees as a result of the suspension, as the company currently anticipates restarting manufacturing at all locations around mid- to late February 2022 based on the information available to date.  For the...

Advanced Diabetes Supply, Inogen, Nabil Shabshab, Portable Oxygen Concentrators


Read Full Articlered right arrow icon

Ali Bauerlein

Vendors

Inogen adjusts channel mix

November 12, 2021Liz Beaulieu, Editor

GOLETA, Calif. – Demand is high, but with supply restricted, Inogen is prioritizing POC orders from its direct-to-consumer channel.  That meant it was unable to fulfill some orders from other channels, particularly its domestic business-to-business channel, which saw sales of $22.8 million in the third quarter, down 1.1% from the same period last year.  "Due to supply chain constraints and in an effort to optimize financial results, we intentionally focused our available capacity...

Inogen, Nabil Shabshab, Portable Oxygen Concentrators


Read Full Articlered right arrow icon

Also Noted

Inogen appoints Glezer chief technology officer

October 13, 2021HME News Staff

GOLETA, Calif. – Inogen has named Stanislav Glezer, M.D., to the role of CTO responsible for R&D and engineering, medical affairs and regulatory affairs. Glezer, who joined Inogen in June, will remain an executive vice president of the company. He has more than 27 years of experience and has held leadership roles at a variety of medical technology and biotechnology firms, including Becton, Dickinson and Company, Adocia S.A., Novo Nordisk, Inc., and Sanofi S.A. “Since joining Inogen...

Inogen, Nabil Shabshab, Stanislav Glazer


Read Full Articlered right arrow icon

Inogen sees challenges ahead

Vendors

Inogen sees challenges ahead

August 6, 2021HME News Staff

GOLETA, Cailf. – Inogen saw a nice boost in revenue in the second quarter, thanks to increasing consumer confidence and ambulation, but the company expects supply chain constraints to inhibit its ability to meet demand in the second half of 2021.  The company expects total revenue for the second half to be lower than the first half of the year, and it expects net losses for the third and fourth quarters, as well as for the full year.  “We continue to see strong consumer...

Inogen, Nabil Shabshab, Oxygen Concentrators


Read Full Articlered right arrow icon

Vendors

Inogen sees significant growth in rental revenues 

May 5, 2021HME News Staff

GOLETA, Calif. – Inogen reported total revenues of $86.9 million for the first quarter of 2021, a 1.8% decrease from the same period last year, primarily due to the impacts of the COVID-19 pandemic, the company says.  It reported a net loss of $732,000 vs. a net loss of $1.59 million.  “While the COVID-19 pandemic continued to have an impact on our business in the first quarter of 2021, we saw sequential growth in all four channels, and sequential growth of 17.5%...

Inogen, Nabil Shabshab, Oxygen Concentrators


Read Full Articlered right arrow icon

Vendors

Inogen sees ‘pull through’ demand for POCs

February 26, 2021Liz Beaulieu, Editor

GOLETA, Calif. – Inogen reported a 17.9% increase in sales of portable oxygen concentrators to HME providers in the fourth quarter of 2020, a sign of just how much the pandemic is straining the supply of stationary oxygen concentrators, a more common therapy for COVID-19 patients.  That’s compared to a 25.2% decrease in direct-to-consumer sales for the quarter.  “Traditionally, these patients are treated...

Inogen, Nabil Shabshab, Oxygen


Read Full Articlered right arrow icon

Vendors

Shabshab takes over

February 26, 2021Liz Beaulieu, Editor

GOLETA, Calif. – Inogen’s new CEO, Nabil Shabshab, says the company may be “placing its bets a little differently” in 2021.  During a recent conference call to discuss the company’s latest financial results, Shabshab’s first, an analyst asked how he planned to balance Inogen’s various business segments – direct to consumer, business to business and rental.   “Of course, (the...

Inogen, Nabil Shabshab, Oxygen


Read Full Articlered right arrow icon

Vendors

Inogen’s domestic B2B sales rebound 

February 25, 2021HME News Staff

GOLETA, Calif. – Inogen reported revenue of $74 million for the fourth quarter of 2020, a 6.3% decrease compared to the same period in 2019, but domestic business-to-business sales were $24.2 million, a 17.9% increase.  Rental revenue was $9.4 million, a 71.7% increase, and direct-to-consumer sales were $26.8 million, a 25.2% decrease.  “While the COVID-19 pandemic continued to have a significant effect on our business in the fourth quarter of 2020, primarily...

Inogen, Nabil Shabshab, Oxygen Concentrators


Read Full Articlered right arrow icon